depending on when a generic of its blockbuster blood pressure drug Diovan makes it to the market in the U.S. Diovan lost its patent in September of 2012, but the release of a copy has been delayed ...

has approved two single-pill combination medications, Diovan HCT(R) (valsartan and hydrochlorothiazide) and Exforge(R) (amlodipine and valsartan), as initial or 'first-line' therapies in patients ...

Valsartan and Hydrochlorothiazide Tablets USP, 80/12.5 mg, 160/12.5 mg, 160/25 mg, 320/12.5 mg and 320/25 mg, had U.S. sales of approximately$1.6 billion for the 12 months ending June 30, 2012 ...

Today it is in the driver’s seat after the agency approved its new generic Diovan to help relieve shortages ... of the ubiquitous high blood pressure drug. It said that its review of Alkem ...

The FDA has approved Novartis’ Diovan HCT (valsartan/hydrochlorothiazide ... hypertension goals and increase compliance by reducing pill burden. These approvals were based on several clinical ...

Diovan, Avapro, Norvasc, Tenormin, Toprol and Cardura Erectile dysfunction pills, like Viagra, Cialis and Levitra. Use a Splitter Having the right equipment is very important too. Don’t use a ...

Problems surrounding the blood pressure-lowering drug Diovan have shed fresh light on opaque and sometimes questionable ties between medical researchers and pharmaceutical firms. More facts behind ...

BASEL -- Swiss drug-maker Novartis AG Wednesday said its best-selling drug, the high-blood-pressure treatment Diovan, was well on track to soon achieve annual sales of $4 billion. At a ...

The Food and Drug Administration (FDA) has expanded the approval of Diovan (valsartan) to include patients 1 to 5 years of age for the treatment of hypertension. Previously, the treatment was ...

has approved two single-pill combination medications, Diovan HCT®[*] (valsartan and hydrochlorothiazide) and Exforge® (amlodipine and valsartan), as initial or 'first-line' therapies in patients ...